The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow COO
The Cooper Companies, Inc. (COO) Revenue growth
The Cooper Companies, Inc.'s revenue growth over the twelve months to 31 July 2026 was 4.73%, down 0.3 percentage points from fiscal 2025 (5.06%). Over the past ten years it has ranged from −8.39% (fiscal 2020) to 20.2% (fiscal 2021); the current reading is higher than 36% of that period. That is below the Medical Instruments & Supplies industry median of 8.85% and below the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 5.06% | (3.35) |
| FY2024 | 8.41% | (0.20) |
| FY2023 | 8.61% | (4.59) |
| FY2022 | 13.2% | (7.02) |
| FY2021 | 20.2% | 28.61 |
| FY2020 | −8.39% | (13.15) |
| FY2019 | 4.76% | (13.65) |
| FY2018 | 18.4% | 9.65 |
| FY2017 | 8.76% | (0.68) |
| FY2016 | 9.44% | 4.82 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jul 2026 | 0.56% | (7.34) |
| Apr 2026 | 7.90% | 1.74 |
| Jan 2026 | 6.16% | 1.57 |
| Oct 2025 | 4.59% | (1.14) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| TFX Teleflex Incorporated compare | 110.9% |
| RGEN Repligen Corporation compare | 16.5% |
| ATR AptarGroup, Inc. compare | 8.93% |
| BLCO Bausch + Lomb Corporation compare | 8.85% |
| BAX Baxter International Inc. compare | 5.36% |
| COO The Cooper Companies, Inc. | 4.73% |
| ALGN Align Technology, Inc. compare | 4.41% |
| SOLV Solventum Corporation compare | −0.93% |
| AVTR Avantor, Inc. compare | −1.57% |
| Medical Instruments & Supplies industry median | 8.85% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on COO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement